【摘要】：目的觀察護(hù)理干預(yù)對促進(jìn)乳腺癌芳香化酶抑制劑治療患者骨健康的效果。方法通過方便抽樣方法選取符合納入標(biāo)準(zhǔn)患者60例,進(jìn)行骨質(zhì)疏松知識問卷調(diào)查和骨密度檢測,然后對其進(jìn)行一對一的個體化知識教育、大課堂教育、持續(xù)電話隨訪和QQ群隨訪等干預(yù),1年后再次進(jìn)行骨質(zhì)疏松知識問卷調(diào)查和骨密度檢測及飲食和鍛煉行為調(diào)查。結(jié)果干預(yù)前骨質(zhì)疏松知識總分均值(13.68±6.08)分,骨質(zhì)疏松危險因素、運(yùn)動知識及鈣知識維度標(biāo)準(zhǔn)分分別為(47.42±26.58)分、(58.33±26.51)分、(54.29±28.91)分,干預(yù)后骨質(zhì)疏松知識總分均值(20.22±3.11)分,骨質(zhì)疏松危險因素、運(yùn)動知識及鈣知識維度標(biāo)準(zhǔn)分分別為(78.79±10.80)分、(73.75±20.80)分、(80.71±19.65)分,干預(yù)前后比較差異有統(tǒng)計(jì)學(xué)意義(P0.05),骨密度檢測干預(yù)后骨質(zhì)正常例數(shù)增多,但干預(yù)前后比較無統(tǒng)計(jì)學(xué)意義(P0.05);同時患者飲食和鍛煉行為方面也有顯著的改進(jìn),建立適應(yīng)個體的飲食結(jié)構(gòu)和鍛煉方式,骨質(zhì)疏松癥狀進(jìn)行了及時的治療。結(jié)論護(hù)理干預(yù)可以促進(jìn)乳腺癌芳香化酶抑制劑治療患者骨健康。
[Abstract]:Objective to observe the effect of nursing intervention on promoting bone health of breast cancer patients treated with aromatase inhibitor. Methods 60 patients who met the inclusion criteria were selected by convenient sampling method. The knowledge of osteoporosis was investigated by questionnaire and bone mineral density (BMD) was measured, and then one-to-one individualized knowledge education and large classroom education were carried out on them. After continuous telephone follow-up and QQ group follow-up, osteoporosis knowledge questionnaire, bone mineral density (BMD) and diet and exercise behavior were investigated again one year later. Results before intervention, the average score of the total knowledge of osteoporosis was (13.68 鹵6.08), the standard scores of osteoporosis risk factors, exercise knowledge and calcium knowledge were (47.42 鹵26.58), (58.33 鹵26.51), (54.29 鹵28.91), respectively. The standard scores of motor knowledge and calcium knowledge were (78.79 鹵10.80), (73.75 鹵20.80), (80.71 鹵19.65), respectively. But there was no significant difference before and after intervention (P0.05); at the same time, there were significant improvements in diet and exercise behavior of patients. Conclusion Nursing intervention can promote bone health of breast cancer patients treated with aromatase inhibitor.
【作者單位】： 浙江省腫瘤醫(yī)院;
【基金】：浙江省中醫(yī)藥科技計(jì)劃課題基金,編號:2013ZB023
【分類號】：R473.73

【相似文獻(xiàn)】

相關(guān)期刊論文 前1條

1 S.Schrading;H.Schild;M.Kühr;C.Kuhl;秦乃姍;;動態(tài)增強(qiáng)乳腺M(fèi)R成像中他莫昔芬及芳香化酶抑制劑對乳腺組織強(qiáng)化的影響:個體內(nèi)縱向隊(duì)列研究[J];國際醫(yī)學(xué)放射學(xué)雜志;2014年03期

，

本文編號：2158925